0000000000398569

AUTHOR

Rafael Marcos Gragera

showing 2 related works from this author

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (…

2022

Abstract Background Survival is a key metric of the effectiveness of a health system in managing cancer. We set out to provide a comprehensive examination of worldwide variation and trends in survival from brain tumors in adults, by histology. Methods We analyzed individual data for adults (15–99 years) diagnosed with a brain tumor (ICD-O-3 topography code C71) during 2000–2014, regardless of tumor behavior. Data underwent a 3-phase quality control as part of CONCORD-3. We estimated net survival for 11 histology groups, using the unbiased nonparametric Pohar Perme estimator. Results The study included 556,237 adults. In 2010–2014, the global range in age-standardized 5-year net survival for…

Cancer ResearchOncologyNeurology (clinical)brain tumor international comparisons net survival population-based cancer registriesSettore MED/42 - Igiene Generale E Applicatabrain tumor ; international comparisons ; net survival ; population-based cancer registries
researchProduct

Survival of Myeloid Malignancies in EUROPE: Results of the HAEMACARE Project.

2009

Abstract Abstract 3911 Poster Board III-847 Background Updated ICD-O and WHO classifications of Haematological Malignancies (HMs) take into account cell lineage, genotype, morphological aspects, immuno-histochemical and genetic characteristics, and clinical behaviour of the disease, dividing Lymphoid and Myeloid neoplasms in subcategories with possible similar aetiology or prognosis. Thus, good quality of morphological data on HMs is capital. The HAEMACARE project aimed to increase standardization and the availability of Cancer Registries (CRs) morphological data on HMs, in order to improve comparability of incidence, survival and prevalence across Europe. This study aims to present the HAE…

Acute leukemiaPediatricsmedicine.medical_specialtyMyeloidRelative survivalbusiness.industryIncidence (epidemiology)ImmunologyMyeloid leukemiaCell BiologyHematologyDiseasemedicine.diseaseBiochemistryLeukemiamedicine.anatomical_structureEtiologymedicinebusinessDemographyBlood
researchProduct